Winklevoss Twins Donate $1.4 Million to Support Zcash Privacy Cryptocurrency
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2d ago
0mins
Source: Benzinga
- Support for Privacy Coins: The Winklevoss twins donated 3,221 ZEC tokens worth $1.4 million to Shielded Labs on Tuesday, demonstrating their long-term commitment to the development of the Zcash network.
- Privacy Frontier: Cameron Winklevoss described Zcash as 'unstoppable private money,' emphasizing the importance of privacy in cryptocurrency and opposing government and corporate overreach.
- Investment Outlook: The significant investment by the Winklevoss twins in Zcash indicates their belief in its potential as a leading privacy protocol, especially as Cypherpunk Technologies Inc. holds 290,062 ZEC valued at over $103 million.
- Market Performance: Zcash was a top performer last year, surging over 600%, while the current trading price of ZEC is $357.10, reflecting a 30% decline year-to-date, indicating market volatility.
Analyst Views on CYPH
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
